Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-276.39M
↓ 185% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-96.94M
Historical baseline
PeriodValueYoY Change
2025$-276.39M-19.0%
2024$-232.32M-26.1%
2023$-184.17M-96.3%
2022$-93.84M-71.9%
2021$-54.58M-83.3%
2020$-29.78M+17.4%
2019$-36.06M-34.3%
2018$-26.84M+4.7%
2017$-28.17M-289.5%
2016$-7.23M-